Boothbay Fund Management LLC Sells 47,853 Shares of Quanterix Co. (NASDAQ:QTRX)

Boothbay Fund Management LLC decreased its position in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) by 21.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 173,645 shares of the company's stock after selling 47,853 shares during the quarter. Boothbay Fund Management LLC owned 0.45% of Quanterix worth $1,846,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in QTRX. Resona Asset Management Co. Ltd. purchased a new stake in shares of Quanterix during the fourth quarter valued at approximately $55,000. Tower Research Capital LLC TRC grew its holdings in shares of Quanterix by 219.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,702 shares of the company's stock valued at $61,000 after buying an additional 3,915 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of Quanterix during the fourth quarter valued at approximately $66,000. Canada Pension Plan Investment Board grew its holdings in shares of Quanterix by 64.5% during the fourth quarter. Canada Pension Plan Investment Board now owns 10,200 shares of the company's stock valued at $108,000 after buying an additional 4,000 shares during the last quarter. Finally, Peapack Gladstone Financial Corp purchased a new stake in shares of Quanterix during the third quarter valued at approximately $131,000. Hedge funds and other institutional investors own 86.48% of the company's stock.

Analyst Upgrades and Downgrades

QTRX has been the topic of a number of recent analyst reports. Canaccord Genuity Group cut their price target on shares of Quanterix from $20.00 to $15.00 and set a "buy" rating on the stock in a report on Tuesday, March 18th. Scotiabank restated an "outperform" rating on shares of Quanterix in a report on Tuesday, March 25th.

Quanterix Trading Down 1.7 %

Shares of QTRX stock opened at $5.78 on Tuesday. Quanterix Co. has a 12-month low of $4.67 and a 12-month high of $19.18. The firm's 50 day moving average is $6.50 and its 200 day moving average is $9.48. The stock has a market capitalization of $224.20 million, a P/E ratio of -5.45 and a beta of 1.35.

Quanterix (NASDAQ:QTRX - Get Free Report) last issued its quarterly earnings results on Monday, March 17th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The business had revenue of $35.16 million for the quarter, compared to analysts' expectations of $34.93 million. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. As a group, equities analysts predict that Quanterix Co. will post -0.98 earnings per share for the current year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Co. (NASDAQ:QTRX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.